Maximus (NYSE:MMS) Sets New 52-Week High – Here’s What Happened

Maximus, Inc. (NYSE:MMS)’s share price hit a new 52-week high on Tuesday . The company traded as high as $99.14 and last traded at $98.1320, with a volume of 15962 shares. The stock had previously closed at $98.32.

Analyst Ratings Changes

Several brokerages recently weighed in on MMS. Zacks Research raised Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Maximus in a research report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Strong Buy”.

Maximus Price Performance

The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $5.33 billion, a price-to-earnings ratio of 17.62 and a beta of 0.56. The stock has a 50-day simple moving average of $87.78 and a 200 day simple moving average of $84.71.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.01). The firm had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.34 billion. Maximus had a net margin of 5.87% and a return on equity of 25.23%. The company’s quarterly revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 13th will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 1.3%. This is an increase from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, February 13th. Maximus’s dividend payout ratio (DPR) is 21.58%.

Insider Transactions at Maximus

In other Maximus news, insider Michelle F. Link sold 4,039 shares of the business’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total value of $350,746.76. Following the transaction, the insider directly owned 19,542 shares in the company, valued at $1,697,027.28. The trade was a 17.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP raised its holdings in Maximus by 2.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock worth $170,812,000 after buying an additional 36,989 shares during the period. Boston Partners raised its position in Maximus by 47.0% in the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock valued at $88,236,000 after buying an additional 308,892 shares during the last quarter. Reinhart Partners LLC. lifted its stake in Maximus by 0.8% in the 3rd quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider’s stock valued at $84,206,000 after acquiring an additional 7,722 shares in the last quarter. Stephens Investment Management Group LLC boosted its position in Maximus by 49.0% during the 3rd quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock worth $65,873,000 after acquiring an additional 237,097 shares during the last quarter. Finally, Federated Hermes Inc. grew its stake in shares of Maximus by 1.3% during the 3rd quarter. Federated Hermes Inc. now owns 688,505 shares of the health services provider’s stock worth $62,909,000 after acquiring an additional 8,847 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.